Skip to search formSkip to main contentSkip to account menu

Opana

Known as: Endo brand of oxymorphine HCl 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Abstract Opana (oxymorphone) is a powerful semi-synthetic opioid agonist used for chronic pain management that is ingested orally… 
2017
2017
BACKGROUND Atypical Haemolytic Uremic Syndrome (aHUS) is a rare life threatening entity characterized by thrombocytopenia… 
2017
2017
Since 2012, a number of case reports have described the occurrence of thrombotic microangiopathy (TMA) following IV abuse of… 
Review
2016
Review
2016
OBJECTIVE Prescription opioid abuse poses a significant public health concern. House Bill 1 (HB1) was enacted in 2012 to address… 
2014
2014
Twenty-nine state attorneys general have asked the FDA to reconsider its approval of the opioid Zohydro, which lacks abuse… 
2013
2013
FDA has denied Endo Health Solutions' petition to block generic forms of its opioid agonist Opana ER, which contains oxymorphone… 
2013
2013
![Figure][1] A 23-year-old white woman with a history of intravenous drug abuse presented to the emergency department with… 
2009
2009
Oxymorphone, a semi-synthetic opioid analgesic, has been available as Numorphan since the 1950s in the form of injectable…